Crossmark

Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)

Crossref DOI link: https://doi.org/10.1007/s40744-022-00491-4

Published Online: 2022-10-17

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wassenberg, Siegfried http://orcid.org/0000-0002-5215-762X
Rau, Rolf

Klopsch, Thilo

Plenske, Anja

Jobst, Jürgen

Klaus, Pascal

Meng, Thomas

Löschmann, Peter-Andreas
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2022-10-17

Version of Record valid from 2022-10-17
More Information

Article History

Received: 7 March 2022

Accepted: 31 August 2022

First Online: 17 October 2022

Change Date: 20 September 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40744-023-00579-5

Change Date: 29 November 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40744-023-00616-3

Updates are available Correction dated 2023-09-20

Click to view Correction: https://doi.org/10.1007/s40744-023-00579-5

Updates are available Correction dated 2023-11-29

Click to view Correction: https://doi.org/10.1007/s40744-023-00616-3